Artificial intelligence (AI) adoption in the global healthcare industry is growing as the technology is increasingly able to tackle complex problems across diverse areas of the industry.
For example, researchers at the Mayo Clinic have developed an AI capable of diagnosing hypertrophic cardiomyopathy, a thickening of the heart that can lead to improper blood pumping. Another group, comprising researchers from Regenstrief Institute, Georgia State, Albert Einstein College of Medicine and Solid Research Group, developed an AI capable of predicting Alzheimer’s disease and dementia risk through scanning electronic health record data. IBM’s Watson Health cognitive computing platform is capable of aiding clinicians in making clearer diagnoses based on patient data and published scientific literature.
